BioLargo, Inc. (OTCQB: BLGO) is developing technology-based products that are looking to solve some of the world’s most important problems that threaten water, food, agriculture, healthcare and energy. The subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) includes the Advanced Oxidation Systems, AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water.
BioLargo also owns a 50% interest in the Isan System. The subsidiary Odor-No-More Inc., are products serving the pet, equine, and consumer markets, including the Nature’s Best Solution(R) and Deodorall(R) brands. (www.OdorNoMore.com). The subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications. Company description can be seen here: www.BioLargo.com
SNNLive caught up with Dennis Calvert, President & CEO of BioLargo, Inc. at the LD Micro Invitational 2015 in Bel Air, CA.
In this interview, Mr. Calvert begins with a brief overview of the company, and continues with an update: “There’s a lot new. Over the last few months, we’ve expanded our research team. As you may recall, we have a research center on campus at the University of Alberta, and in that center we have a team of researchers. We have accumulated approximately eight (8) grants, another three (3) in the process of closing, another four (4) in the process of getting to paper.” He goes on to explain how the Company’s technology has gotten the attention of public funding agencies throughout Canada.
Mr. Calvert then discusses the path to commercialization for the Company’s technology. For more information about BioLargo, Inc., go to: www.BioLargo.com
© 2017 Stock News Now
Supported by Superior Web Solutions